Reliable Biopharmaceutical Corporation Announces Facility Expansion for High Purity Ingredients

Reliable Biopharmaceutical Corporation (RBC) announced today that it has invested several million dollars into its High Purity production suites. These investments will nearly triple the production capacity in its High Purity Ingredients (HPI) line.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

St. Louis, Missouri (PRWEB) April 22, 2013

Reliable Biopharmaceutical Corporation (RBC) announced today that it has invested several million dollars into its High Purity production suites. These investments will nearly triple the production capacity in its High Purity Ingredients (HPI) line.

RBC currently produces USP/EP Urea, and detergents including Sodium Dodecyl sulfate (SDS) and Lithium Dodecyl sulfate(LDS) in its High Purity Line. The capacity was needed to expand the product line to include a full line of fully validated biological buffers.

Lance Kunkel, Vice President Operations at Reliable Biopharmaceutical Corporation said, “It is always a great opportunity to be a part of growing business. The customers’ demand for our products required us to expand the facility in order to continue to meet their growing needs.”

David Feldker, President and CEO, Reliable Biopharmaceutical Corporation commented, “This expansion will provide the additional capacity necessary to introduce our products to new customers, so they too can experience the superior quality and service provided by RBC.”

About Reliable Biopharmaceutical Corporation
Founded in 1968, RBC is an integrated developer and manufacturer of Active Pharmaceutical Ingredients (APIs) and High Purity Ingredients (HPIs) for pharmaceuticals and biologics. RBC has established a strong position as a leading developer and manufacturer of complex generic injectable APIs. The company has 19 DMFs that have been accepted by Regulatory Agencies and has 19 more in various stages of development. RBC's products are the active ingredients for leading generic injectable drugs that treat cancer, heart disease, hypertension, anxiety and other serious and life threatening illnesses. RBC also manufactures critical processing aids for the pharmaceutical industry and currently supplies these products to many of the world's leading pharmaceutical and biotechnology companies.

For more information, contact:
Reliable Biopharmaceutical Corporation
James Wickenhauser, Vice President Sales and Marketing
(314) 429-7700
1945 Walton Road
St. Louis, Mo 63114


Contact

  • James Wickenhauser
    jwickenhauser@reliablebiopharm.com
    314.429.7700
    Email

Attachments